Skip to content
healthcare.dev

EYLEA HD

NDC 61755-050, aflibercept, injection, solution, from Regeneron Pharmaceuticals, Inc.

Product NDC
61755-050
Status
Listed
Labeler
Regeneron Pharmaceuticals, Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761355
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61755-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AFLIBERCEPT8 mg/.07mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
61755-050-01617550050011 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-01) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-00)
61755-050-51617550050511 VIAL, SINGLE-DOSE in 1 CARTON (61755-050-51) / .07 mL in 1 VIAL, SINGLE-DOSE (61755-050-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/86d8848b-111b-4da9-8957-7cccef1b8f66
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61755-050

Use it

Look up 61755-050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61755-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61755-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.